Key result
VA-ECMO and Impella 5.5 linked to fatal neurological injury in a fulminant myocarditis case.
Why the study?
The rare combination of refractory cardiogenic shock with acute severe mitral regurgitation from papillary muscle rupture illustrates therapeutic challenges with temporary mechanical circulatory support.
Case Report (n=1)
This case illustrates the therapeutic challenges of managing fulminant myocarditis complicated by papillary muscle rupture and cardiogenic shock, demonstrating the use of VA-ECMO and Impella 5.5 for stabilization, though complicated by fatal neurological injury.
Answers are grounded in this paper and cite their sources.
Warrants caution using tMCS for myocarditis with papillary muscle rupture; leaves open surgical intervention in profound cardiogenic shock.
We present a case of acute-on-recurrent viral myocarditis complicated by papillary muscle rupture of the mitral valve. This rare clinical scenario, combining refractory cardiogenic shock with acute severe mitral valve regurgitation, illustrates the therapeutic challenges associated with temporary mechanical circulatory support (tMCS). Although mitral valve replacement would theoretically correct the mechanical complication, cardiac surgery in the setting of profound cardiogenic and septic shock carries a high risk of failure. In this context, the combination of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) with left ventricular unloading using a micro-axial pump (Impella 5.5, Abiomed, USA) appeared to us to be the most appropriate strategy, offering time for stabilisation before surgical intervention. Despite intensive support and targeted immunomodulatory treatment, the patient presented with severe neurological injury, ultimately leading to withdrawal of life-sustaining therapies.
No takes yet. Share an insight, caveat, or question.
Lajoye et al. (2026) conducted a case report in Acute-on-recurrent viral myocarditis complicated by papillary muscle rupture and cardiogenic shock (n=1). VA-ECMO with left ventricular unloading using a micro-axial pump (Impella 5.5) was evaluated. In 1 patient with fulminant myocarditis and cardiogenic shock, management with VA-ECMO and Impella 5.5 ultimately led to severe neurological injury and withdrawal of life-sustaining therapies.
Synapse has enriched 10 related papers. Consider them for comparative context: